TG THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
TG THERAPEUTICS, INC. (TGTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 2.98 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2023-03-01
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-12-31 was 75.00K shares.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-06-30 was 25.00K shares, a 66.67% decline year-over-year.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-03-31 was 715.00K shares, a 47.42% increase year-over-year.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 2.98M shares.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2020 was 75.00K shares, a 90.80% decline from fiscal 2019.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2019 was 815.00K shares.
- TG THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2022-12-31 | 2.98M shares 10-K · filed 2023-03-01 | |||
| 2020-12-31 | 75.00K shares 10-K · filed 2023-03-01 | |||
| 2019-12-31 | 75.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 75.00K shares derived: sum of 2 quarters · filed 2022-03-01 | 100.00K shares derived: sum of 3 quarters · filed 2022-03-01 | 815.00K shares 10-K · filed 2022-03-01 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 25.00K shares derived: sum of 2 quarters · filed 2019-11-12 | 740.00K shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 25.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 740.00K shares 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | 715.00K shares 10-Q · filed 2019-05-10 | |||
| 2018-09-30 | 50.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 125.00K shares derived: sum of 2 quarters · filed 2018-11-09 | 610.00K shares 10-Q · filed 2018-11-09 | |
| 2018-06-30 | 75.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 560.00K shares 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | 485.00K shares 10-Q · filed 2018-05-10 | |||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-09 | |||
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2015-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2015-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 0.00 shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-14 | 0.00 shares 10-Q · filed 2014-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-16 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | 0.00 shares 10-Q · filed 2014-07-24 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-16 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-16 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-16 | 0.00 shares 10-K · filed 2015-03-16 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-14 | 0.00 shares 10-Q · filed 2013-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2014-03-07 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 0.00 shares 10-Q · filed 2013-08-09 | 0.00 shares derived: sum of 3 quarters · filed 2014-03-07 | 46.00K shares derived: sum of 4 quarters · filed 2014-03-07 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-07 | 46.00K shares derived: sum of 3 quarters · filed 2014-03-07 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | 46.00K shares derived: sum of 2 quarters · filed 2014-03-07 | 46.00K shares 10-K · filed 2014-03-07 | |
| 2012-09-30 | 46.00K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | 46.00K shares 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | 0.00 shares 10-Q/A · filed 2012-09-07 | |||
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |